Skip to content

HLA–Microbiota interactions shaping immune-mediated diseases initiation and progression

The interplay between immunogenetics and the human microbiota has emerged as a focal point in unraveling the complexities of immune mediated diseases. While HLA alleles are established as significant risk factors across multiple immune disorders, recent evidence highlights that their impact is modulated by the composition and activity of the host’s microbiome. Ongoing research has demonstrated that certain microbes may provoke abnormal immune responses specifically in individuals who harbor susceptible HLA variants, suggesting a finely tuned dialog between host genetic background, microbial exposures, and immune function. Conversely, some commensal organisms may offer protection and help maintain immune tolerance, adding another layer of intricacy to disease susceptibility.Despite substantial progress, the field continues to grapple with critical questions regarding why only some genetically at-risk individuals develop autoimmunity, and why similar environmental exposures do not uniformly yield the same outcomes. Notably, it is now clear that the genesis and course of autoimmunity cannot be attributed to genetics or environment alone, but rather to a complex combination where gene–microbe interactions may be pivotal. Identifying the mechanisms and mediating factors in these interactions is a central challenge with high relevance for understanding disease heterogeneity, risk prediction, and novel therapeutic avenues.This Research Topic aims to promote an integrated exploration of how HLA variants and microbiota interplay in the onset and progression not only of autoimmune diseases, but to all immune mediated diseases (transplantation, infection, immunodeficiencies...)Key objectives include elucidating the molecular mechanisms of these interactions, clarifying causal relationships, and assessing how microbial composition may mediate genetic risk or confer resilience. By uniting work across immunology, genetics, microbiology, and clinical research, this collection aspires to clarify how variable combinations of genes and microbes govern susceptibility and resistance to autoimmunity and immune mediated diseases.To gather further insights in the intersection of host genetics, microbiota, and immune-mediated diseases, we welcome articles addressing, but not limited to, the following themes:~ Mechanisms by which HLA alleles influence the composition and function of the microbiota on the modulation of immune disorders~ Microbial triggers of autoimmunity in genetically susceptible hosts~ Protective roles of commensals and their interactions with the immune system~ Microbiota-driven modulation of antigen presentation and immune reactivity~ Longitudinal and comparative studies of HLA–microbiota interactions in different immune disorders~ Translational approaches and therapeutic implications targeting host–microbe crosstalk~ Advances in models and technologies for studying gene–microbiome–immunity axesAppendix: We welcome the submission of original research articles, reviews, perspectives, and methodological studies relevant to these themes. Topic editors: Juan Francisco Gutiérrez Bautista, Ana María Marín-Sánchez, Antonio Sampedro, Zongkui Wang Source: https://www.frontiersin.org/research-topics/77541/hla-microbiota-interactions-shaping-immune-mediated-diseases-initiation-and-progression

Open for submissionsHosted by Frontiers in Immunology
Contribute to this topic

Articles in this collection

No articles published in this topic yet.